Keratitis Bacterial
4
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by Difluprednate
Research Leaders
9 sponsors active, led by Vishal Jhanji
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Fluorometholone Study
Steroids and Cross-linking for Ulcer Treatment
Validation of Interleukins and Other Cytokines Together With OCT Imaging for Rapid Infectious Keratitis Assessment
Microbiologic Alterations of the Conjunctiva of Hot Tub-soaking Ophthalmologists
Research Network
Common Treatments
- Difluprednate1
- Dunk1
- Tear Sample Probe1
- Adjunctive Topical Fluorometholone Fml 011
- Standard Topical Antibiotic Therapy1
Active Sponsors
- Vishal Jhanji1
- University of Pittsburgh Medical Center1
- Johannes Kepler University of Linz1
- Aravind Eye Care System1
- National Eye Institute (NEI)1
Top Investigators
Stanford University
Stanford University
University of California, San Francisco
JKU Linz
UCSF/Proctor Foundation
Related Conditions
- Corneal Ulcer Diagnosis1
- Keratitis Fungal1
- Conjunctivitis Bacterial1